Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01321606 · ClinicalTrials.gov registry record · Phase 2
Impact of Probiotics for Reducing Infections in Veterans: The IMPROVE Study
A Phase 2 study, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- Phase 2
- Development phase
- 113
- Enrollment target
NCT01321606: Completed Phase 2 study, sponsored by VA Office of Research and Development.
NCT01321606 is a Phase 2 study that has completed, run by VA Office of Research and Development. The registered enrollment target is 113 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01321606, a Phase 2 study, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 113 participants
- Enrollment target
Study Summary
The investigators have two hypotheses: (1) The probiotic L. rhamnosus HN001, when compared to placebo, will reduce S. aureus nasal colonization when taken for four weeks. (2) The probiotic L. rhamnosus HN001, when compared to placebo, will reduce S. aureus gastrointestinal colonization when taken for four weeks.
Interventions
- DIETARY_SUPPLEMENT sugar pill (placebo)
- DIETARY_SUPPLEMENT Lactobacillus rhamnosus HN001
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 113 participants |
| Start Date | 2011-10 |
| Est. Completion | 2015-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01321606
The ClinicalTrials.gov registry entry for NCT01321606 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 113 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which sugar pill (placebo) is the first listed.
NCT01321606 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01321606 about?
NCT01321606 is a clinical study titled "Impact of Probiotics for Reducing Infections in Veterans: The IMPROVE Study". The investigators have two hypotheses: (1) The probiotic L. rhamnosus HN001, when compared to placebo, will reduce S. aureus nasal colonization when taken for four weeks. (2) The probiotic L. rhamnosus HN001, when compared to placebo, will reduce S. aureus gastrointestinal colonization when taken fo...
What is the current status of trial NCT01321606?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 113 participants. The study started on 2011-10. Estimated completion is 2015-12.
What interventions are being tested in trial NCT01321606?
The interventions under investigation include: sugar pill (placebo) (DIETARY_SUPPLEMENT), Lactobacillus rhamnosus HN001 (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01321606?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.